文献速递疝与腹壁外科围术期管理与 ERAS

Rives-Stoppa修补术后切口疝复发的预测因素:回顾性队列研究

Predictors of hernia recurrence after Rives-Stoppa repair in the treatment of incisional hernias: a retrospective cohort.
PubMed 文献 · Surg Endosc · 2018-11-19

该回顾性队列研究纳入213例接受Rives-Stoppa后鞘修补的切口疝患者,中位随访57.6个月,复发率7.1%。多因素分析显示使用类固醇或免疫抑制剂、术后血肿形成及需手术处理的血肿是复发的独立预测因素。

要点

  • 使用类固醇或免疫抑制剂使复发风险增加(OR 2.02)。
  • 术后血肿形成及需手术处理的血肿均与复发风险升高相关。
  • 肥胖、吸烟、急诊修补、补片固定方式等未显示与复发显著相关。

核心结论

  • 使用免疫抑制药物、术后血肿形成及需手术处理的血肿与Rives-Stoppa修补术后疝复发风险增加相关。

研究设计与样本

  • 回顾性观察性研究,纳入2007年6月至2014年1月在一家三级中心接受Rives-Stoppa后鞘修补的213例成人中线切口疝患者。

主要发现

  • 中位随访57.6个月(范围46-75个月),共报告15例复发(7.1%),复发平均出现在术后19.4个月(范围2-49个月)。
  • 多因素分析显示,使用类固醇或免疫抑制药物(OR 2.02;CI 1.16-3.95,p=0.004)、术后血肿形成(OR 2.9;CI 1.55-4.10,p=0.001)及需手术处理的血肿(OR 2.1;CI 1.21-3.29,p=0.004)是复发的预测因素。
  • 肥胖、吸烟、急诊修补、补片固定方式、手术时间、补片类型或同期手术与复发率无显著差异。

关键数值与推荐

  • 纳入标准为成人中线疝,EHS分类为M1、M2、M3、M4或M5,且横向疝缺损测量大于5 cm(W2和W3级)。

临床怎么用

  • 对于接受Rives-Stoppa修补的切口疝患者,应关注免疫抑制药物使用及术后血肿的预防与处理,以降低复发风险。

局限性

  • 本研究为单中心回顾性观察性研究,样本量有限,可能存在选择偏倚和未测量的混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Rives-Stoppa retromuscular repair (RSR) has been traditionally used to provide adequate coverage for large abdominal wall defects and appears to be more advantageous compared to other surgical techniques concerning complications and recurrence rates. The aim of this study was to identify the independent predictors associated to hernia recurrence after RSR in the treatment of incisional hernias. METHODS: This is a retrospective observational study of 213 patients who underwent RSR between June 2007 and January 2014 at a tertiary centre. Main inclusion criteria were adults with midline hernia classified as M1, M2, M3, M4, or M5, according to EHS classification. All the cases presented a transverse hernia defect measurement greater than 5 cm (grades W2 and W3). Recurrence rate was determined by clinical examination plus confirmation by abdominal CT scan. RESULTS: At a median of 57.6 months (range 46-75 months) of postoperative follow-up, we reported 15 cases of recurrence (7.1%). Recurrences occurred after a mean period of 19.4 months (range 2-49 months). On multivariate analysis, steroid or immunosuppressive drugs use (OR 2.02; CI 1.16-3.95, p = 0.004), the development of postoperative hematoma (OR 2.9; CI 1.55-4.10, p = 0.001), and needing surgery for the hematoma (OR 2.1; CI 1.21-3.29, p = 0.004) were predictors of recurrence after RSR. There was no significant difference in recurrence rate among obesity, smoking, urgent repair, type of mesh fixation, operative time, type of prosthesis, or concomitant procedures. CONCLUSIONS: In our current study, using immunosuppressive drugs, the development of postoperative hematoma and needing surgery for the hematoma were associated with increased risk of hernia recurrence after RSR.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Bueno-Lledó J, Torregrosa A, Jiménez-Rosellón R, et al. Predictors of hernia recurrence after Rives-Stoppa repair in the treatment of incisional hernias: a retrospective cohort. Surg Endosc. 2018. PMID: 30456504. doi:10.1007/s00464-018-6597-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。